BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28081204)

  • 41. Potential use of an unencapsulated and aromatic amino acid-auxotrophic Streptococcus suis mutant as a live attenuated vaccine in swine.
    Fittipaldi N; Harel J; D'Amours B; Lacouture S; Kobisch M; Gottschalk M
    Vaccine; 2007 May; 25(18):3524-35. PubMed ID: 17296252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contribution of glutamine synthetase to the virulence of Streptococcus suis serotype 2.
    Si Y; Yuan F; Chang H; Liu X; Li H; Cai K; Xu Z; Huang Q; Bei W; Chen H
    Vet Microbiol; 2009 Oct; 139(1-2):80-8. PubMed ID: 19447571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel virulence-associated protein, vapE, in Streptococcus suis serotype 2.
    Ji X; Sun Y; Liu J; Zhu L; Guo X; Lang X; Feng S
    Mol Med Rep; 2016 Mar; 13(3):2871-7. PubMed ID: 26821177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibronectin-/fibrinogen-binding protein (FBPS) is not a critical virulence factor for the Streptococcus suis serotype 2 strain ZY05719.
    Li Q; Fu Y; He Y; Zhang Y; Qian Y; Yu Y; Yao H; Lu C; Zhang W
    Vet Microbiol; 2017 Sep; 208():38-46. PubMed ID: 28888647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Streptococcus suis vaccines: candidate antigens and progress.
    Segura M
    Expert Rev Vaccines; 2015; 14(12):1587-608. PubMed ID: 26468755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a novel DNase of Streptococcus suis (EndAsuis) important for neutrophil extracellular trap degradation during exponential growth.
    de Buhr N; Stehr M; Neumann A; Naim HY; Valentin-Weigand P; von Köckritz-Blickwede M; Baums CG
    Microbiology (Reading); 2015 Apr; 161(Pt 4):838-50. PubMed ID: 25667008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The type II histidine triad protein HtpsC facilitates invasion of epithelial cells by highly virulent Streptococcus suis serotype 2.
    Lu Y; Li S; Shen X; Zhao Y; Zhou D; Hu D; Cai X; Lu L; Xiong X; Li M; Cao M
    J Microbiol; 2021 Oct; 59(10):949-957. PubMed ID: 34491523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation on a Streptococcus suis vaccine using recombinant sao-l protein manufactured by bioreactors as the antigen in pigs.
    Hsueh KJ; Lee JW; Hou SM; Chen HS; Chang TC; Chu CY
    Transbound Emerg Dis; 2014 Dec; 61(6):e35-43. PubMed ID: 23489297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SsPep contributes to the virulence of Streptococcus suis.
    Tan C; Liu M; Li J; Jin M; Bei W; Chen H
    Microb Pathog; 2011 Nov; 51(5):319-24. PubMed ID: 21839825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A serine/threonine phosphatase 1 of
    Fang L; Zhou J; Fan P; Yang Y; Shen H; Fang W
    J Vet Sci; 2017 Dec; 18(4):439-447. PubMed ID: 28057904
    [No Abstract]   [Full Text] [Related]  

  • 51. HP0487 contributes to the virulence of Streptococcus suis serotype 2 by mediating bacterial adhesion and anti-phagocytosis to neutrophils.
    Hui X; Xu Z; Cao L; Liu L; Lin X; Yang Y; Sun X; Zhang Q; Jin M
    Vet Microbiol; 2021 Sep; 260():109164. PubMed ID: 34247113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significant contribution of the pgdA gene to the virulence of Streptococcus suis.
    Fittipaldi N; Sekizaki T; Takamatsu D; de la Cruz Domínguez-Punaro M; Harel J; Bui NK; Vollmer W; Gottschalk M
    Mol Microbiol; 2008 Dec; 70(5):1120-35. PubMed ID: 18990186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The VraSR regulatory system contributes to virulence in Streptococcus suis via resistance to innate immune defenses.
    Chang P; Li W; Shi G; Li H; Yang X; Xia Z; Ren Y; Li Z; Chen H; Bei W
    Virulence; 2018 Dec; 9(1):771-782. PubMed ID: 29471718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. VirA: a virulence-related gene of Streptococcus suis serotype 2.
    Li P; Liu J; Zhu L; Qi C; Bei W; Cai X; Sun Y; Feng S
    Microb Pathog; 2010 Nov; 49(5):305-10. PubMed ID: 20624451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenicity and protective ability of RpoE against Streptococcus suis serotype 2.
    Yi L; Du Y; Mao C; Li J; Jin M; Sun L; Wang Y
    J Appl Microbiol; 2021 Apr; 130(4):1075-1083. PubMed ID: 32996241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The genetically modified suilysin, rSLY(P353L), provides a candidate vaccine that suppresses proinflammatory response and reduces fatality following infection with Streptococcus suis.
    Du H; Huang W; Xie H; Ye C; Jing H; Ren Z; Xu J
    Vaccine; 2013 Aug; 31(38):4209-15. PubMed ID: 23856333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The 1910HK/RR two-component system is essential for the virulence of Streptococcus suis serotype 2.
    Yuan F; Tan C; Liu Z; Yang K; Zhou D; Liu W; Duan Z; Guo R; Chen H; Tian Y; Bei W
    Microb Pathog; 2017 Mar; 104():137-145. PubMed ID: 28093234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Construction and virulence evaluation of the virB1-89K gene knockout mutant of type IV-like secretion system of Streptococcus suis serotype 2].
    Zhong Q; Li M; Zhao Y; Chen T; Yin S; Wang M; Rao X; Tan Y; Hu F
    Wei Sheng Wu Xue Bao; 2013 Mar; 53(3):276-83. PubMed ID: 23678574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Redox-Sensing Regulator Rex Contributes to the Virulence and Oxidative Stress Response of
    Zhu H; Wang Y; Ni Y; Zhou J; Han L; Yu Z; Mao A; Wang D; Fan H; He K
    Front Cell Infect Microbiol; 2018; 8():317. PubMed ID: 30280091
    [No Abstract]   [Full Text] [Related]  

  • 60. Disruption of srtA gene in Streptococcus suis results in decreased interactions with endothelial cells and extracellular matrix proteins.
    Vanier G; Sekizaki T; Domínguez-Punaro MC; Esgleas M; Osaki M; Takamatsu D; Segura M; Gottschalk M
    Vet Microbiol; 2008 Mar; 127(3-4):417-24. PubMed ID: 17954016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.